Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
|
Mid-range Performer
2124.5000
41.50
(
1.99
%)
NSE
Sep 21, 2026
15:31 PM
Volume:
429.1K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
16 Feb 2026
2124.50
1.99%
Result Update:Lupin
Buy:
Lupin Ltd.
by
Axis Direct
Target: 2460 | Target met
Target
Axis Direct
We recommend a BUY rating with a target price of Rs 2,460/share.
Number of FII/FPI investors increased from 979 to 999 in Jun 2026 qtr.
More from Lupin Ltd.
Recommended
NSE listing and fresh IPOs put primary market in focus
|
21 Sep 2026, 07:11PM
Market closes higher, led by gains in pharma and realty stocks
Trendlyne Marketwatch |
21 Sep 2026, 03:55PM
Lupin expects normalization by September quarter
|
17 Apr 2020